Syros Pharmaceuticals Inc (SYRS)
5.44
+0.04
(+0.74%)
USD |
NASDAQ |
May 01, 16:00
5.47
+0.03
(+0.55%)
After-Hours: 20:00
Syros Pharmaceuticals Revenue (TTM): 9.935M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.935M |
| September 30, 2023 | 8.795M |
| June 30, 2023 | 8.924M |
| March 31, 2023 | 12.37M |
| December 31, 2022 | 14.88M |
| September 30, 2022 | 23.44M |
| June 30, 2022 | 25.24M |
| March 31, 2022 | 24.13M |
| December 31, 2021 | 23.49M |
| September 30, 2021 | 21.38M |
| June 30, 2021 | 19.52M |
| Date | Value |
|---|---|
| March 31, 2021 | 17.54M |
| December 31, 2020 | 15.09M |
| September 30, 2020 | 9.903M |
| June 30, 2020 | 6.633M |
| March 31, 2020 | 3.907M |
| December 31, 2019 | 1.982M |
| September 30, 2019 | 2.367M |
| June 30, 2019 | 2.221M |
| March 31, 2019 | 2.134M |
| December 31, 2018 | 2.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.982M
Minimum
Dec 2019
25.24M
Maximum
Jun 2022
13.25M
Average
12.37M
Median
Mar 2023
Revenue (TTM) Benchmarks
| PDS Biotechnology Corp | -- |
| PAVmed Inc | 2.452M |
| Moderna Inc | 6.754B |
| Altimmune Inc | 0.426M |
| iBio Inc | -- |